HealthEquity Cost of Goods Sold 2014-2024 | HQY
HealthEquity annual/quarterly cost of goods sold history and growth rate from 2014 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- HealthEquity cost of goods sold for the quarter ending October 31, 2024 was $0.103B, a 14.85% increase year-over-year.
- HealthEquity cost of goods sold for the twelve months ending October 31, 2024 was $0.399B, a 6.17% increase year-over-year.
- HealthEquity annual cost of goods sold for 2024 was $0.377B, a 1.93% increase from 2023.
- HealthEquity annual cost of goods sold for 2023 was $0.37B, a 11.46% increase from 2022.
- HealthEquity annual cost of goods sold for 2022 was $0.332B, a 4.26% increase from 2021.
| HealthEquity Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $377 |
| 2023 | $370 |
| 2022 | $332 |
| 2021 | $318 |
| 2020 | $206 |
| 2019 | $106 |
| 2018 | $95 |
| 2017 | $72 |
| 2016 | $54 |
| 2015 | $40 |
| 2014 | $29 |
| 2013 | $22 |
| HealthEquity Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-10-31 | $103 |
| 2024-07-31 | $96 |
| 2024-04-30 | $100 |
| 2024-01-31 | $99 |
| 2023-10-31 | $90 |
| 2023-07-31 | $92 |
| 2023-04-30 | $96 |
| 2023-01-31 | $98 |
| 2022-10-31 | $89 |
| 2022-07-31 | $88 |
| 2022-04-30 | $95 |
| 2022-01-31 | $97 |
| 2021-10-31 | $77 |
| 2021-07-31 | $77 |
| 2021-04-30 | $81 |
| 2021-01-31 | $87 |
| 2020-10-31 | $75 |
| 2020-07-31 | $74 |
| 2020-04-30 | $82 |
| 2020-01-31 | $88 |
| 2019-10-31 | $61 |
| 2019-07-31 | $28 |
| 2019-04-30 | $29 |
| 2019-01-31 | $31 |
| 2018-10-31 | $25 |
| 2018-07-31 | $24 |
| 2018-04-30 | $26 |
| 2018-01-31 | $29 |
| 2017-10-31 | $23 |
| 2017-07-31 | $21 |
| 2017-04-30 | $22 |
| 2017-01-31 | $23 |
| 2016-10-31 | $17 |
| 2016-07-31 | $16 |
| 2016-04-30 | $16 |
| 2016-01-31 | $17 |
| 2015-10-31 | $13 |
| 2015-07-31 | $12 |
| 2015-04-30 | $12 |
| 2015-01-31 | $12 |
| 2014-10-31 | $10 |
| 2014-07-31 | $9 |
| 2014-04-30 | $9 |
| 2014-01-31 | |
| 2013-10-31 | $7 |
| 2013-07-31 | $7 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.569B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $160.880B | 29.74 |
| Elevance Health (ELV) | United States | $91.772B | 12.00 |
| Cencora (COR) | United States | $49.134B | 18.48 |
| Natera (NTRA) | United States | $23.357B | 0.00 |
| DiDi Global (DIDIY) | China | $22.601B | 0.00 |
| ICON (ICLR) | Ireland | $16.423B | 14.63 |
| Revvity (RVTY) | United States | $15.350B | 25.74 |
| Avantor (AVTR) | United States | $15.164B | 22.74 |
| BioMerieux (BMXMF) | France | $14.363B | 0.00 |
| Viatris (VTRS) | United States | $13.464B | 4.15 |
| CochLear (CHEOY) | Australia | $13.043B | 0.00 |
| Solventum (SOLV) | United States | $12.794B | 0.00 |
| Doximity (DOCS) | United States | $11.033B | 64.94 |
| Medpace Holdings (MEDP) | United States | $10.852B | 30.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.405B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.425B | 16.28 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.114B | 28.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 87.41 |
| Organon (OGN) | United States | $4.007B | 4.04 |
| Sotera Health (SHC) | United States | $3.883B | 20.77 |
| Surgery Partners (SGRY) | United States | $3.240B | 36.94 |
| Concentras Parent (CON) | United States | $2.968B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.950B | 0.00 |
| PACS (PACS) | United States | $2.214B | 0.00 |
| Premier (PINC) | United States | $2.178B | 11.33 |
| Ardent Health Partners (ARDT) | United States | $2.141B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.056B | 0.00 |
| Progyny (PGNY) | United States | $1.973B | 39.95 |
| GoodRx Holdings (GDRX) | United States | $1.818B | 47.70 |
| Teladoc Health (TDOC) | United States | $1.749B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.376B | 0.00 |
| CareDx (CDNA) | United States | $1.250B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.201B | 11.75 |
| AMN Healthcare Services Inc (AMN) | United States | $1.048B | 7.09 |
| Embecta (EMBC) | United States | $1.042B | 7.29 |
| Establishment Labs Holdings (ESTA) | $0.897B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.515B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.499B | 18.81 |
| Sonida Senior Living (SNDA) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| QDM (QDMI) | Hong Kong, SAR China | $0.412B | 0.00 |
| MultiPlan (MPLN) | United States | $0.295B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.295B | 0.00 |
| Nutex Health (NUTX) | United States | $0.259B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.108B | 18.32 |
| Oncology Institute (TOI) | United States | $0.076B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| ModivCare (MODV) | United States | $0.057B | 3.10 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |